PD1 space has 7 marketing now , in the monoclonal space. Big dollars, $15K a month for treatments
GSK paid $5.1 billion for TESARO ( Jemerli, and others) in 2018. Just now getting FDA nod .
like all monoclonals, significant side effects. Jemperli shrunk tumours in 42.3%, compared to Keytruda triggering response in 36%.
5.1 billion was in US dollars. What’s IMU worth , with its pipeline , if it’s proven to work?
https://www.fiercepharma.com/pharma/latecomer-glaxosmithkline-ushers-7th-pd-1-l1-fda-nod-for-jemperli-treading-keytruda-ground
Media Thread, page-1049
-
- There are more pages in this discussion • 14,111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.4¢ |
Change
0.002(2.88%) |
Mkt cap ! $382.1M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.4¢ | 5.2¢ | $220.3K | 4.167M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 933996 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 3426188 | 18 |
View Market Depth
| Last trade - 13.21pm 21/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |